Stoke Therapeutics Inc.

STOK | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.59

+$0.54 (+1.93%)

Sep 22, 2026, 12:04 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-6.89M	-88.98M	-104.7M	-101.07M	-85.81M	-52.24M
Depreciation & Amortization	1.77M	2.18M	2.47M	1.55M	974K	888K
Stock-Based Compensation	32.24M	27.47M	25.26M	22.85M	16.45M	5.77M
Other Working Capital	-675K	-31.23M	-2.82M	42.9M	-2.85M	-2.88M
Other Non-Cash Items	2.12M	623K	1.94M	1.78M	1.26M	1.04M
Deferred Income Tax	n/a	n/a	n/a	n/a	172K	3K
Change in Working Capital	16.35M	-28.14M	-6.03M	43.02M	46K	2.33M
Operating Cash Flow	45.59M	-86.85M	-81.07M	-31.87M	-66.91M	-42.22M
Capital Expenditures	-670K	-203K	-1.62M	-3.96M	-1.2M	-1.05M
Cash Acquisitions	n/a	n/a	n/a	45.34M	75.23M	n/a
Purchase of Investments	-322.72M	-167.27M	n/a	-201.32M	-87.23M	n/a
Sales Maturities Of Investments	136.58M	60M	107.56M	159.4M	12M	n/a
Other Investing Acitivies	n/a	n/a	n/a	-45.34M	-75.23M	n/a
Investing Cash Flow	-186.81M	-107.48M	105.95M	-45.88M	-76.43M	-1.05M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	2.25M	926K	1.07M	-2K	2.71M
Financial Cash Flow	97.39M	131.09M	53.01M	46.41M	1.28M	108.11M
Net Cash Flow	-43.84M	-63.23M	77.89M	-31.34M	-142.05M	64.84M
Free Cash Flow	44.92M	-87.05M	-82.68M	-35.83M	-68.11M	-43.27M
Adj. Free Cash Flow	12.68M	-114.52M	-107.94M	-58.68M	-84.56M	-49.04M
Maintenance CapEx	n/a	n/a	-1.62M	n/a	-974K	-888K
Growth CapEx	-670K	-203K	n/a	-3.96M	-226K	-162K
Owner Earnings	45.59M	-86.85M	-82.68M	-31.87M	-67.88M	-43.11M